Waters Michael Willem 4

4 · Teladoc Health, Inc. · Filed Mar 5, 2024

Form 4

Period: 2024-03-01

CHIEF OPERATING OFFICER

Transactions

Exercise/Conversion
Common Stock
2024-03-01+8,452→ 47,022 total
Exercise/Conversion
Common Stock
2024-03-01+24,801→ 71,823 total
Sale
Common Stock
2024-03-04$14.52/sh−12,468$180,985→ 59,355 total
Award
Performance Stock Units
2024-03-01+25,357→ 25,357 total
→ Common Stock (25,357 underlying)
Exercise/Conversion
Performance Stock Units
2024-03-01−8,452→ 16,905 total
→ Common Stock (8,452 underlying)
Exercise/Conversion
Restricted Stock Units
2024-03-01−24,801→ 49,604 total
→ Common Stock (24,801 underlying)

Footnotes (8)

[F1]Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
[F2]Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
[F3]Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.
[F4]Each performance stock unit represents a contingent right to receive one share of TDOC common stock.
[F5]Performance award amount determined based on metrics in respect of the issuer's 2023 financial results.
[F6]The performance stock units vest as to one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
[F7]On March 1, 2024, the reporting person earned 25,357 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
[F8]On March 3, 2023, the reporting person was granted 74,405 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.

Documents

1 file